AUTUMN CHAMPION: Open Payments
NPI 1336439322 · LA FOLLETTE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 45 payments from 13 companies in 2025. Trend: 2023 $810 · 2024 $1,500 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $332 |
| Novo Nordisk Inc | 7 | $265 |
| AstraZeneca Pharmaceuticals LP | 7 | $244 |
| Averitas Pharma Inc. | 2 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| Abbott Laboratories | 3 | $72 |
| CeQur Corporation | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: QULIPTA, Wegovy, Ozempic, BREZTRI, UBRELVY, QUTENZA, XIFAXAN, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
